Wednesday, 26 August 2026European Markets

EURASIA FONC INV Stock Falls By 24% In The Last 10 Sessions

Loading stream...

(vianews) - shares of eurasia fonc inv (cac 40: efi.pa) slid by a staggering 24.62% in 10 sessions from €0.4 to €0.30 at 14:53 est on friday, after five consecutive sessions in a row of losses. cac 40 is rising 0.44% to €7,514.01, after four successive sessions in a row of gains.

about eurasia fonc inv

eurasia fonciere investissements société anonyme owns, develops, and manages corporate and commercial real estate assets. the company was formerly known as mb retail europe and changed its name to eurasia fonciere investissements société anonyme in january 2012. the company was founded in 1984 and is headquartered in paris, france. eurasia fonciere investissements société anonyme is a subsidiary of eurasia groupe sa.

earnings per share

as for profitability, eurasia fonc inv has a trailing twelve months eps of €-0.01.

volume

today's last reported volume for eurasia fonc inv is 7558 which is 252.11% above its average volume of 284.

volatility

eurasia fonc inv's last week, last month's, and last quarter's current intraday variation average was a negative 47.33%, a negative 1.36%, and a positive 10.07%.

eurasia fonc inv's highest amplitude of average volatility was 47.33% (last week), 10.70% (last month), and 10.07% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eurasia fonc inv's stock is considered to be overbought (>=80).

more news about eurasia fonc inv (efi.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com